ARGS
Vanguard Group’s Argos Therapeutics, Inc. ARGS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-1,045,386
| Closed | -$157K | – | 4159 |
|
|
2017
Q4 | $157K | Buy |
1,045,386
+194,151
| +23% | +$29.2K | ﹤0.01% | 3962 |
|
|
2017
Q3 | $152K | Buy |
851,235
+71,200
| +9% | +$12.7K | ﹤0.01% | 3953 |
|
|
2017
Q2 | $284K | Sell |
780,035
-67,088
| -8% | -$24.4K | ﹤0.01% | 3837 |
|
|
2017
Q1 | $382K | Buy |
847,123
+64,787
| +8% | +$29.2K | ﹤0.01% | 3803 |
|
|
2016
Q4 | $3.83M | Buy |
782,336
+46,955
| +6% | +$230K | ﹤0.01% | 3151 |
|
|
2016
Q3 | $3.66M | Buy |
735,381
+357,884
| +95% | +$1.78M | ﹤0.01% | 3148 |
|
|
2016
Q2 | $2.31M | Buy |
377,497
+137,390
| +57% | +$842K | ﹤0.01% | 3332 |
|
|
2016
Q1 | $1.54M | Buy |
240,107
+75,542
| +46% | +$484K | ﹤0.01% | 3464 |
|
|
2015
Q4 | $380K | Buy |
164,565
+7,400
| +5% | +$17.1K | ﹤0.01% | 3895 |
|
|
2015
Q3 | $762K | Buy |
157,165
+7,680
| +5% | +$37.2K | ﹤0.01% | 3719 |
|
|
2015
Q2 | $1.02M | Buy |
149,485
+6,280
| +4% | +$43K | ﹤0.01% | 3659 |
|
|
2015
Q1 | $1.28M | Buy |
143,205
+17,362
| +14% | +$155K | ﹤0.01% | 3565 |
|
|
2014
Q4 | $1.26M | Buy |
125,843
+1,000
| +0.8% | +$10K | ﹤0.01% | 3450 |
|
|
2014
Q3 | $1.26M | Buy |
124,843
+19,412
| +18% | +$195K | ﹤0.01% | 3443 |
|
|
2014
Q2 | $847K | Sell |
105,431
-6,968
| -6% | -$56K | ﹤0.01% | 3527 |
|
|
2014
Q1 | $1.12M | Buy |
+112,399
| New | +$1.12M | ﹤0.01% | 3417 |
|